Absci Corp. (ABSI)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Absci Corp. (ABSI)
Go deeper and ask any question about ABSI
Company Performance
Current Price
as of Sep 13, 2024$3.90
P/E Ratio
N/A
Market Cap
$442.87M
Description
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Metrics
Overview
- HQVancouver, WA
- SectorHealth Technology
- IndustryBiotechnology
- TickerABSI
- Price$3.9+5.69%
Trading Information
- Market Cap$442.87M
- Float80.59%
- Average Daily Volume (1m)920,466
- Average Daily Volume (3m)1,542,694
- EPS-$0.93
Company
- Revenue$3.25M
- Rev Growth (1yr)-62.28%
- Net Income-$24.75M
- Gross Margin-166.46%
- EBITDA Margin-1,837.56%
- EBITDA-$23.34M
- EV$199.42M
- EV/Revenue61.36
- P/EN/A
- P/S135.52
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset